Search PubMed⌕ Search

Biomedical subjects

C Misch

Publications and source records attributed to C Misch.

12 recordsLinked to original sources
PubMed1997

Triiodothyronine (T3) reflects renal graft function after renal transplantation.

OBJECTIVE: Abnormalities in thyroid function are observed in patients with end stage renal disease. However, there are no data available evaluating sequential changes of thyroid function after renal transplantation. Therefore, we have studied thyroid hormone function in the immediate post-operative period after renal transplantation in order to determine the relationship between improving renal function and changes in thyroid hormone economy. DESIGN AND PATIENTS: Thyroid function was evaluated in 22 patients before and on days 1, 3, 7 and 15 after renal transplantation. All patients received prednisone and cyclosporin as immunosuppressive therapy. Twelve patients with normal renal function undergoing comparable surgical procedures served as a control group. MEASUREMENTS: Serum creatinine and thyroid hormone parameters (total T4, total T3, free T4, free T3, thyroxin binding globulin (TBG), reverse T3, T3 sulphate and TSH) were measured. RESULTS: According to post-operative kidney function after renal transplantation, patients could be subdivided into three groups: five patients had primary graft function (group I); seven patients had delayed graft function because of acute renal failure (group II); 10 patients had delayed graft function requiring high doses of prednisone and some also of OKT3 because of acute rejection (group III). There was a significant fall in T3 and T4 concentrations with a concomitant rise in reverse T3 in all patients up to 3 days after renal transplantation. However, only patients in group I reached pre-operative values on day 15 after renal transplantation (serum creatinine 167 +/- 52 microM), whereas patients in group II (creatinine 609 +/- 118 microM) and group III (creatinine 839 +/- 71 microM) continued to have T3 concentrations well in the hypothyroid range (group I, 1.68 +/- 0.28 nM) vs 0.87 +/- 0.09 nM in group II and 0.76 +/- 0.10 nM in group III; P < 0.01). Serum T4 concentrations were also low in group III (47.7 nM vs 100.2 nM in group I; P < 0.05) 15 days after renal transplantation. These changes were accompanied by a concomitant fall in T3/TBG ratio and in free T3. Elevated reverse T3 returned to normal values in all groups on the 15th day after renal transplantation. TSH fell significantly on the first post-operative day, but did not return to pre-operative values in renal transplantation patients. In the control group, TSH did not change during the study period. T3 sulphate, known to be elevated in chronic renal failure, remained above normal in all patients irrespective of graft function during this study period. CONCLUSIONS: T3 concentrations reflect renal graft function after renal transplantation. T3 is below normal in patients with delayed graft function (acute renal failure or acute rejection). The post-operative period (up to 3 days after renal transplantation) is associated with a low T3 syndrome. TSH does not return to pre-operative values even in patients with primary graft function. This might be due to the administration of prednisone. T3-sulphate is elevated before and after renal transplantation irrespective of graft function.

Acute Kidney Injury↗
PubMed1995

The maxillary anterior single tooth implant aesthetic-health compromise.

With implant function established as a predictable treatment modality, the emphasis during the last decade has shifted to aesthetic of the restoration, particularly in the maxillary anterior area, sometimes to the extent of compromise of hygiene in the cervical region. The author reviews the aesthetics-hygiene compromise, in the context of long-term maintenance and survival, and suggests a compromise in cervical aesthetics in "unaesthetic" areas and even in the maxillary anterior if the cervical region is not exposed with broad smile. The presentation is a reminder that aesthetics is not the only criteria for an implant crown. The aesthetic-health compromise must be considered and understood prior to the treatment so that the most appropriate treatment plan can be developed.

Alveolar Process↗
PubMed1992

Sinus lift grafts and endosseous implants. Treatment of the atrophic posterior maxilla.

Patients from multicenters were treated with sinus lift graft operations and placement of implants. Surgical procedures healed uneventfully with minimum pain, swelling, or morbidity. Grafts healed with few complications or failures. Implants placed into the grafts support prosthetic reconstruction and are predictable over time. The question of what graft material to use is discussed. Grafts of non-resorbable HA (Interpore 200), bovine cortical HA (Bio-Oss), resorbable HA (OsteoGen), and freeze-dried demineralized bone powder and granules are presented. Results of biopsy, histometry, backscattered electron microscopy, cell labeling, and special stain suggest consistent bone growth into a variety of graft materials. In the authors' opinion investigation must continue to 1. Determine the healing time for different graft materials. At present, anecdotal evidence suggests that sinus grafts of autogenous bone heal for 4 to 6 months; freeze-dried demineralized bone heals for 12 to 16 months; and alloplastic materials with freeze-dried demineralized bone heal for 9 to 11 months. 2. Evaluate histologic evidence of bone growth into different bone replacement graft materials. 3. Evaluate the long-term follow-up and success of implants placed within sinus grafts. 4. Determine the remodeling potential of different hard tissue graft materials under implant functional loads.

Atrophy↗